Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
Although there are abundant data highlighting the safety and efficacy of direct oral anticoagulants, to date, recent guidelines have limited their use to stroke prevention in patients with non-valvular AF, as well as in the prevention and treatment of venous thromboembolism and pulmonary embolism. E...
Main Authors: | Mahmoud Abdelnabi, Abdallah Almaghraby, Yehia Saleh |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2020-02-01
|
Series: | European Cardiology Review |
Online Access: | https://www.ecrjournal.com/articleindex/ecr.2019.1.3 |
Similar Items
-
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
by: Mahmoud Abdelnabi, et al.
Published: (2022-03-01) -
Hepatocellular carcinoma with a direct right atrial extension in an HCV patient previously treated with direct-acting antiviral therapy: a case report
by: Mahmoud Abdelnabi, et al.
Published: (2019-09-01) -
An idiopathic giant right atrium aneurysm in old asymptomatic patient
by: Abdallah Almaghraby, et al.
Published: (2020-01-01) -
Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
by: Mahmoud Abdelnabi, et al.
Published: (2020-06-01) -
Ivabradine and AF: Coincidence, Correlation or a New Treatment?
by: Mahmoud Abdelnabi, et al.
Published: (2020-01-01)